Journal Information
Vol. 162. Issue 3.
Pages 141-142 (February 2024)
Vol. 162. Issue 3.
Pages 141-142 (February 2024)
Letter to the Editor
Innovative use of telitacicept in Ehlers–Danlos syndrome
Aplicación innovadora de telitaccicept en el síndrome de Ehlers-Danlos
a Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, Sichuan, China
b Department of Rheumatology and Immunology, Nanchong Central Hospital, The Affiliated Nanchong Central Hospital of North Sichuan Medical College, Nanchong, Sichuan, China
c Inflammation and Immunology Key Laboratory of Nanchong, Nanchong, Sichuan, China
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail